Hypertension and insulin resistance

Hypertension

Volumn 54, Issue 3, 2009, Pages 462-464

  Whaley Connell, Adam ^a,b   Sowers, James R ^a,b  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; FATTY ACID; LEVACECARNINE; ACETYLCARNITINE; VITAMIN B COMPLEX;

BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; FATTY ACID METABOLISM; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MITOCHONDRIAL MEMBRANE; NOTE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; BIOLOGICAL MODEL; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ACETYLCARNITINE; ADMINISTRATION, ORAL; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; VITAMIN B COMPLEX;

EID: 70349240548     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.134460     Document Type: Note

References (8)

1. Sowers JR, Whaley-Connell, Epstein M. The emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med. 2009;150:776-783.
2. Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008;102:401-414.
3. Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Kahn BB, Papademetris X, Rothman DL, Shulman GI. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A. 2007;104:12587-12594.
4. Ruggenenti P, Cattaneo D, Loriga G, Ledda F, Motterlini N, Gherardi G, Orisio S, Remuzzi G. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy. Hypertension. 2009;54:567-574.
5. Mingrone G. Carnitine in type 2 diabetes. Ann N Y Acad Sci. 2004;1033:99-107.
6. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci. 2004;1033:30-41.
7. Stephens FB, Constantin-Teodosiu D, Greenhaff PL. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol. 2007;581:431-444.
8. Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique C, Stas S, Sowers JR. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol. 2007;293:H2009-H2023.